Rapamycin attenuates bone cancer pain and tumor progression associated with reduced NE/NETosis-related molecular signatures in a mouse model
- DOI
- 10.1016/j.intimp.2026.117610
- Published
- 2026-12
- Container
- International Immunopharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2026.117610,
title = {Rapamycin attenuates bone cancer pain and tumor progression associated with reduced NE/NETosis-related molecular signatures in a mouse model},
author = {Wen Li and Xiaochen Wang and Long Wang and Guo Tang and Yang Li and Zeguo Feng},
year = {2026},
journal = {International Immunopharmacology},
doi = {10.1016/j.intimp.2026.117610},
url = {https://doi.org/10.1016/j.intimp.2026.117610}
}RIS
TY - JOUR TI - Rapamycin attenuates bone cancer pain and tumor progression associated with reduced NE/NETosis-related molecular signatures in a mouse model AU - Wen Li AU - Xiaochen Wang AU - Long Wang AU - Guo Tang AU - Yang Li AU - Zeguo Feng PY - 2026 JO - International Immunopharmacology DO - 10.1016/j.intimp.2026.117610 UR - https://doi.org/10.1016/j.intimp.2026.117610 ER -
APA
Li, W., Wang, X., Wang, L., Tang, G., Li, Y., & Feng, Z. (2026). Rapamycin attenuates bone cancer pain and tumor progression associated with reduced NE/NETosis-related molecular signatures in a mouse model. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117610
Source records
- crossref · retrieved 2026-11-05T21:17:47.412Z